Literature DB >> 11489087

Large reduction in the number of galanin-immunoreactive cells in pancreatic islets of diabetic rats.

E Adeghate1, A S Ponery.   

Abstract

Although galanin has been shown to be present in pancreatic islet cells, there is no literature available on the pattern of distribution and the effect of galanin in the pancreas of diabetic animals or human models. The aim of this study was to examine whether galanin immunoreactivity changes after the onset of diabetes mellitus in the rat model. The present study used immunohistochemical techniques to examine the pattern of distribution of galanin-like immunoreactive cells in the pancreas of rats with streptozotocin-induced diabetes. The effect of galanin on insulin secretion from intact rat pancreatic tissue fragments was also investigated using a radioimmunoassay technique. Numerous galanin-like immunoreactive cells were observed in both the peripheral and central regions of the islet of Langerhans of normal rat pancreas. By contrast, the islets of diabetic rat pancreas contained significantly (P < 0.0001) fewer galanin-like immunoreactive cells than nondiabetic rats. Galanin was colocalized with insulin in the islets of normal and diabetic rats. Galanin had an inhibitory effect on insulin secretion from the isolated pancreatic tissue fragments of normal and diabetic rats at all concentrations (10(-12) to 10(-6) M) employed. Galanin at 10(-9) M caused a significant (P < 0.02) decrease in insulin secretion from normal rat pancreatic tissue fragments compared to basal. These observations indicate that galanin may play a significant role in the regulation of insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11489087     DOI: 10.1046/j.1365-2826.2001.00682.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  5 in total

1.  Go2 G protein mediates galanin inhibitory effects on insulin release from pancreatic β cells.

Authors:  Guanghua Tang; Ying Wang; Sangeun Park; Neil S Bajpayee; Diana Vi; Yoshiko Nagaoka; Lutz Birnbaumer; Meisheng Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Development of a high-throughput screening-compatible cell-based functional assay to identify small molecule probes of the galanin 3 receptor (GalR3).

Authors:  James Robinson; Anthony Smith; Emmanuel Sturchler; Sahba Tabrizifard; Theodore Kamenecka; Patricia McDonald
Journal:  Assay Drug Dev Technol       Date:  2013-10-12       Impact factor: 1.738

3.  Diabetes Mellitus Alters the Immuno-Expression of Neuronal Nitric Oxide Synthase in the Rat Pancreas.

Authors:  Bright Starling Emerald; Sahar Mohsin; Crystal D'Souza; Annie John; Hussain El-Hasasna; Shreesh Ojha; Haider Raza; Basel Al-Ramadi; Ernest Adeghate
Journal:  Int J Mol Sci       Date:  2022-04-29       Impact factor: 6.208

4.  Galanin regulates blood glucose level in the zebrafish: a morphological and functional study.

Authors:  P Podlasz; A Jakimiuk; M Chmielewska-Krzesinska; N Kasica; N Nowik; J Kaleczyc
Journal:  Histochem Cell Biol       Date:  2015-10-26       Impact factor: 4.304

Review 5.  Role of Melatonin, Galanin, and RFamide Neuropeptides QRFP26 and QRFP43 in the Neuroendocrine Control of Pancreatic β-Cell Function.

Authors:  Iacopo Gesmundo; Tania Villanova; Dana Banfi; Giacomo Gamba; Riccarda Granata
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-03       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.